Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 29 2021

Full Issue

Studies Link Mental Illness Diagnosis With Worse Covid Risks

Meta-analyses published in JAMA suggest that people who are diagnosed with a mental illness have a higher risk of being hospitalized or dying from covid. Reasons why include barriers to accessing care. Other research shows that for 40% of people with covid, symptoms can linger for up to six months.

CIDRAP: Mental Illness Tied To Higher Risk Of COVID Hospital Care, Death

Two new JAMA Psychiatry meta-analyses link mental illness with COVID-19 death, with one also finding an association with hospitalization. ... The higher rate of severe COVID-19 "suggests that other factors lead to this health inequity in patients with mental health disorders, including several factors such as barriers to access to care, social determinants of health, immunological disturbances, and the effects of psychotropic drugs," the study authors wrote. (Van Beusekom, 7/28)

CIDRAP: Study: 40% Still Had COVID Symptoms 1 To 6 Months After Hospital Release

Forty percent of 290 COVID-19 survivors completing an Emory University survey 1 to 6 months after release from the hospital reported lingering symptoms such as fatigue, shortness of breath on exertion, and "mental fog." The study, published yesterday in Open Forum Infectious Diseases, involved an emailed survey about persistent COVID-19 symptoms, acute illness severity, and quality of life to better quantify and characterize "long COVID." (7/28)

CIDRAP: New Metric Shows COVID-19 Reduced Lifespan Significantly

COVID-19 reduced lifespan by up to 9 years in parts of the United States, per a new "mean unfulfilled lifespan" (MUL) metric, according to a study published yesterday in PLOS One. The MUL is a new indicator of the impact of mortality shocks, such as the novel coronavirus or other natural disaster, on peoples' lifespan. (7/28)

NPR: COVID Symptoms May Linger In Some Vaccinated People Who Get Infected, Study Finds

There's more potentially worrisome news for vaccinated people: In very rare cases, people experiencing breakthrough infections may be at risk for long-COVID symptoms. That's according to a small new study of fully vaccinated health care workers in Israel, published Wednesday in The New England Journal of Medicine. The study confirmed what's already known: That it's very rare for fully vaccinated people to get infected or sick with COVID-19. But it also found lingering COVID symptoms did develop in a handful of breakthrough cases. (Stein, 7/28)

CNBC: Vaccine Effectiveness For Delta: Immune System Explained

There’s been a lot of news around research out of New York University that suggests the Johnson & Johnson Covid vaccine is less effective against the delta variant, because it triggers fewer antibodies. And many are questioning whether, several months out, people’s antibody levels will wane and require a booster shot. Antibody levels are one piece of the puzzle when it comes to fighting Covid, but they don’t tell the whole story when it comes to immunity. (Stieg, 7/28)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF